Discover the press release issued on April 16, 2025.

In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope

Following a scientific pre-launch in December 2024, our Japanese teams officially presented our antimicrobial-free solution at the annual congress of the Japanese Society of Veterinary Dermatology, held on March 8th and 9th in Tokyo. Recommended as a first-line treatment for canine acute erythemato-ceruminous otitis externa, even with microbial proliferation, our approach offers an effective and safe alternative.